February 21, 2024 by Chain Drug Review
Loblaw to invest more than $2 billion in the Canadian economy, opening more than 40 additional stores
Leading Headlines, Retail News
BRAMPTON, ON – Loblaw Cos., Canada’s food and pharmacy retail leader, expects to invest more than $2 billion dollars into the Canadian economy in 2024. This record investment reflects Loblaw’s commitment to enhancing its store network, creating job opportunities, and improving accessibility to affordable food and healthcare services for communities across the country. The Company’s capital investments this
February 21, 2024 by Chain Drug Review
Cepham introduces Senolytics inspired by Ayurveda and TCM for sustainable aging
Supplier News
SOMERSET, N.J. — Cepham, a leader in Ayurvedic nutraceuticals research and sustainable self-care solutions, has announced the expansion of its Sustainable Aging product line to include senolytics, aimed at redefining approaches to healthy aging. Senescent cells are colloquially known as “zombie cells” among scientists, due to their lingering presence in the body, which can lead
February 7, 2024 by Chain Drug Review
CVS, fourth quarter
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health topped analysts’ forecasts for fourth quarter sales and profits, but cut its full year earnings outlook, citing rising medical costs that are hurting the insurance industry. Revenue for the three months ended December 31 climbed 11.9% from the year-ago period to $93.81 billion, beating Wall Street’s estimate of $90.41 billion.
January 31, 2024 by Chain Drug Review
Discount Drug Mart, vehicle registration
Leading Headlines, Retail News
LAKEWOOD, Ohio — Discount Drug Mart, the regional chain that “Saves you the Run Around,” is now saving time on vehicle registration renewals. A new self-service Ohio Bureau of Motor Vehicles Express Kiosk opened at the Medina, Ohio-based retailer’s store at 15412 Detroit Road in Lakewood, letting drivers renew their registration and receive their validation
January 4, 2024 by Chain Drug Review
first quarter, Pessina, WBA, Wentworth
Featured Articles, Leading Headlines
DEERFIELD, Ill. — Walgreens Boots Alliance topped Wall Street’s expectations for first quarter sales and earnings, but slashed its quarterly dividend nearly in half. WBA cut its dividend to 25 cents per share from 48 cents per share, reducing the payout for the first time in nearly five decades. New CEO Tim Wentworth, who took
December 11, 2023 by Chain Drug Review
NACDS praises House passage of bipartisan bill to help deliver essential PBM reforms in Medicaid
Leading Headlines, Pharmacy
WASHINGTON — NACDS is applauding the passage of the Lower Costs, More Transparency Act (H.R. 5378) by the U.S. House of Representatives today. The bill — which was introduced by U.S. Representative Cathy McMorris Rodgers (R-WA) on September 8 — is a vital aspect of pharmacy benefit manager (PBM) reform. Among its provisions, it addresses the “pharmaceutical
December 6, 2023 by Chain Drug Review
ALS, Coya, Dr. Reddy’s
Leading Headlines, Pharmacy
HOUSTON — Dr. Reddy’s Laboratories is collaborating with Coya Therapeutics Inc. to develop and commercialize an investigational combination therapy for the treatment of amyotrophic lateral sclerosis (ALS). Coya has granted Dr. Reddy’s an exclusive license to commercialize Coya 302, a proprietary co-pack kit containing a combination of low dose IL-2 and CTLA-4 Ig (abatacept) in
December 5, 2023 by Chain Drug Review
Lily, Omvoh
Pharmacy
INDIANAPOLIS — The Food and Drug Administration has approved Eli Lilly and Co.’s Omvoh (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), as the first and only interleukin-23p19 (IL-23p19) antagonist for the treatment of moderately to severely active ulcerative colitis (UC) in adults. Omvoh is the only UC treatment that selectively targets the p19 subunit of
November 8, 2023 by Chain Drug Review
NCPA urges swift action on Senate PBM bills
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association applauds the Senate Finance Committee for passage of Better Mental Health Care, Lower-Cost Drugs, and Extenders Act provisions that would require the Centers for Medicare & Medicaid Services to define reasonable and relevant contract terms under Medicare Part D and create a process for pharmacies to report contract
November 1, 2023 by Chain Drug Review
CVS, third quarter
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — CVS Health topped Wall Street’s estimates for third quarter revenue and earnings. Adjusted earnings per share of $2.21 exceeded analysts’ predicted $2.13, while revenue of $89.76 billion beat the forecast of $88.2 billion. “Our colleagues helped us deliver another quarter of positive results across our business areas,” said president and CEO Karen
October 16, 2023 by Chain Drug Review
Chapter 11 bankruptcy, Jeffrey Stein, Rite Aid
Business, Featured Articles, Leading Headlines, Retail News
PHILADELPHIA — Rite Aid Corp. on Sunday announced that it has filed for Chapter 11 bankruptcy protection as part of a voluntary restructuring plan that the company says will reduce its debt, increase its financial flexibility, and allow it to accelerate its ongoing business transformation. In connection with this process, Rite Aid said it has
October 13, 2023 by Chain Drug Review
Edgewell, Langley
Supplier News
SHELTON, Conn. _ LaTanya Langley has been appointed to the newly created post of chief people and legal officer at Edgewell Personal Care Co., effective November 6. Langley has been the company’s chief legal officer. Her appointment and the establishment of the new position comes with the planned departure of chief human resources officer John
October 2, 2023 by Chain Drug Review
David Pinto, Hy-Vee makes Iowa a scintillating retailing center
October 2, 2023, Opinion
If you happen to find yourself with a few idle days on your hands (How silly: Retailers seldom have a few extra days on their hands), you just might want to wander over to Des Moines, capital of Iowa, to examine how Hy-Vee, one of the truly stunning retailers this or any country has to
September 28, 2023 by Chain Drug Review
CVS pharmacist walkout
Leading Headlines, Retail News
KANSAS CITY — CVS pharmacies here were unaffected Wednesday by a threatened pharmacist walkout. The threat was reported by USA Today, which also had a story about a pharmacist walkout in the area over the weekend. At least a dozen CVS pharmacies in the metropolitan area— many inside Target stores — temporarily closed late last